Fibulin-2 staining was observed to be diffusely cytoplasmic in tumour cells, and more intense in the grade II tumours (Figure 2a), with 64% of grade II meningiomas staining strongly compared to 40% in the grade I cohort (Supplementary data S1). Here, FBLN2 is linked to meningioma.